100
Participants
Start Date
September 30, 1997
paclitaxel
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York
Memorial Sloan-Kettering Cancer Center, New York
Albert Einstein Comprehensive Cancer Center, The Bronx
New York Medical College, Valhalla
Rochester General Hospital, Rochester
Veterans Affairs Medical Center - Washington, DC, Washington D.C.
Duke Comprehensive Cancer Center, Durham
Palmetto Hematology/Oncology Associates, Spartanburg
Hollings Cancer Center, Charleston
Savannah Hematology Oncology Associates, Savannah
Florida Cancer Specialists, Fort Myers
Cancer Center of Southern Alabama, Mobile
Akron City Hospital, Akron
Michiana Hematology/Oncology P.C., South Bend
Medical College of Wisconsin, Milwaukee
Missoula Medical Oncology P.C., Missoula
Northwest Medical Specialists, P.C., Arlington Heights
Louisiana Oncology Associates, Lafayette
Oncology Consultants, Houston
Lone Star Oncology, Austin
Harrington Cancer Center, Amarillo
Nevada Cancer Center, Las Vegas
Loma Linda University Medical Center, Loma Linda
Veterans Affairs Medical Center - San Francisco, San Francisco
Siouxland Hematology-Oncology, Sioux City
Beth Israel Deaconess Medical Center, Boston
Memorial Hospital, Worcester
University of Medicine and Dentistry of New Jersey - MOBILE, Newark
Pitt County Memorial Hospital, Greenville
University of Texas - MD Anderson Cancer Center, Houston
Lead Sponsor
Theradex
INDUSTRY